Target intelligence / Profile preview

Gardnerella species

Molecular classification
Other
01

Overview

Gardnerella species, primarily Gardnerella vaginalis, are Gram-variable, facultative anaerobic bacteria that are central to the pathogenesis of bacterial vaginosis (BV) [StatPearls, 2023; Nature Reviews Microbiology, 2011]. These bacteria are known for their ability to adhere to vaginal epithelial cells, forming characteristic "clue cells" and developing robust, multi-species biofilms that protect them from host immune responses and antibiotic penetration [Nature Reviews Microbiology, 2011; BMC Microbiology, 2015]. Gardnerella species produce several virulence factors, including vaginolysin, a cholesterol-dependent cytolysin that causes host cell lysis, and sialidases that degrade the protective mucus layer of the vaginal tract [Journal of Infectious Diseases, 2005; Clinical Microbiology Reviews, 2019]. In clinical practice, these organisms are the primary targets of antimicrobial therapy using nitroimidazoles like metronidazole or lincosamides like clindamycin [CDC, 2021; StatPearls, 2023]. However, the persistence of Gardnerella within biofilms often leads to high rates of treatment failure and recurrence, posing a significant challenge in women's health [Nature Reviews Microbiology, 2011; Clinical Microbiology Reviews, 2019]. Emerging research also explores the role of Gardnerella in increasing susceptibility to other sexually transmitted infections, including HIV [Nature Reviews Microbiology, 2011].

Other names
Gardnerella vaginalisHaemophilus vaginalisCorynebacterium vaginale
02

Mechanism of action

Inhibition of DNA synthesis via reductive activation of nitro groups (nitroimidazoles) or inhibition of protein synthesis by binding to the 50S ribosomal subunit (lincosamides).

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Antibiotic resistanceRecurrence of infectionDisruption of commensal Lactobacillus speciesVulvovaginal candidiasis
06

Interacting drugs

Metronidazole

3 more in the full profile.

07

Biomarkers

Clue cellsNugent scoreAmsel criteriaSialidase activity

Beyond the preview

Go deeper on Gardnerella species.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gardnerella species.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call